Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
Clinical trial NCT03041688 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03041688
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2027-06-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.